Pricing Log in Create free account

Amgen Inc. (AMGN) vs Eli Lilly and Company (LLY)

Amgen Inc. and Eli Lilly and Company are both Drug Manufacturers General companies. Eli Lilly and Company is the larger, with a market value of $1.28T against $248.8B — 5.2× the size. Amgen Inc. trades at the lower P/E: 26.6× against 44.5×. Eli Lilly and Company grew revenue faster over the last twelve months: 45.5% against 8.15%. Eli Lilly and Company has the higher net margin (31.9% vs 24.1%) and the higher return on invested capital (26.4% vs 14.3%). Both pay a dividend; Amgen Inc. yields more (2.15% vs 0.49%). Across the 23 metrics below, Eli Lilly and Company leads on 12 and Amgen Inc. on 11.

Valuation

Metric AMGN LLY Drug Manufacturers General median
P/E 26.57 44.47 26.57
P/S 6.42 14.13 3.49
P/B 21.38 30.35 5.20
Price to free cash flow 27.32 55.90 21.34
EV/EBITDA 17.63 34.37 14.80
EV/Sales 7.47 14.70 4.09
Earnings yield 3.76% 2.25% 2.40%
Free cash flow yield 3.66% 1.79% 4.43%

Profitability

Metric AMGN LLY Drug Manufacturers General median
Gross margin 70.90% 83.64% 73.01%
Operating margin 32.41% 40.27% 18.34%
Net margin 24.14% 31.90% 7.31%
Free cash flow margin 24.63% 22.74% 18.52%
Return on equity 78.35% 86.02% 5.80%
Return on assets 10.09% 20.97% 2.28%
Return on invested capital 14.29% 26.42% 6.26%

Growth

Metric AMGN LLY Drug Manufacturers General median
Revenue growth (TTM) 8.15% 45.51% 6.72%
EPS growth (last fiscal year) 88.23% 95.99% 21.81%
Revenue growth, 5-year CAGR 7.65% 21.58% 4.75%
Net income growth, 5-year CAGR 1.20% 27.22% 0.00%

Health

Metric AMGN LLY Drug Manufacturers General median
Debt to equity 3.76 1.17 0.63
Current ratio 1.48 1.39 1.39
Net debt to EBITDA 2.94 1.19 1.15

Dividend

Metric AMGN LLY Drug Manufacturers General median
Dividend yield 2.15% 0.49% 2.31%
Payout ratio 0.58 0.22 0.59

Size

Metric AMGN LLY Drug Manufacturers General median
Market cap 248.84b 1.28t 131.21b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack